Your browser doesn't support javascript.
loading
Antitumor activity of aumolertinib, a third-generation EGFR tyrosine kinase inhibitor, in non-small-cell lung cancer harboring uncommon EGFR mutations.
Shi, Chen; Zhang, Cong; Fu, Zhiwen; Liu, Jinmei; Zhou, Yuanfeng; Cheng, Bao; Wang, Cong; Li, Shijun; Zhang, Yu.
Affiliation
  • Shi C; Department of Pharmacy, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.
  • Zhang C; Hubei Province Clinical Research Center for Precision Medicine for Critical Illness, Wuhan 430022, China.
  • Fu Z; Department of Pharmacy, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.
  • Liu J; Department of Pharmacy, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.
  • Zhou Y; Department of Pharmacy, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.
  • Cheng B; Department of Preclinical Translational Science, Shanghai Hansoh Biomedical Co., Ltd., Shanghai 201203, China.
  • Wang C; Department of Chemistry, Shanghai Hansoh Biomedical Co., Ltd., Shanghai 201203, China.
  • Li S; Department of Pharmacy, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.
  • Zhang Y; Department of Pharmacy, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.
Acta Pharm Sin B ; 13(6): 2613-2627, 2023 Jun.
Article in En | MEDLINE | ID: mdl-37425047
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: Acta Pharm Sin B Year: 2023 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: Acta Pharm Sin B Year: 2023 Document type: Article Affiliation country: Country of publication: